Biltekin B
ORCID: 0000-0002-8435-6797
· 1 paper in corpus
Background: Ovarian cancer (OC) is characterized by aggressive progression, high metastatic potential, and frequent resistance to conventional chemotherapy, highlighting the need for novel combination-based therapeutic strategies. Metformin…